Published in J Appl Genet on January 01, 2005
Post mortem identification of deoxyguanosine kinase (DGUOK) gene mutations combined with impaired glucose homeostasis and iron overload features in four infants with severe progressive liver failure. J Appl Genet (2010) 0.84
The DNA Polymerase Gamma R953C Mutant Is Associated with Antiretroviral Therapy-Induced Mitochondrial Toxicity. Antimicrob Agents Chemother (2016) 0.75
Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease. PLoS One (2010) 1.42
Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses. Eur J Hum Genet (2006) 1.41
Staphylococcus aureus as an infectious agent: overview of biochemistry and molecular genetics of its pathogenicity. Acta Biochim Pol (2009) 1.31
Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice. Mol Genet Metab (2009) 1.26
Differential efficiency of induction of various lambdoid prophages responsible for production of Shiga toxins in response to different induction agents. Microb Pathog (2009) 1.18
Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway. J Biomed Sci (2009) 1.14
Effects of the presence of ColE1 plasmid DNA in Escherichia coli on the host cell metabolism. Microb Cell Fact (2006) 1.12
Hydrogen peroxide-mediated induction of the Shiga toxin-converting lambdoid prophage ST2-8624 in Escherichia coli O157:H7. FEMS Immunol Med Microbiol (2009) 1.09
Simple method for plating Escherichia coli bacteriophages forming very small plaques or no plaques under standard conditions. Appl Environ Microbiol (2008) 1.07
A role for bacteriophage T4 rI gene function in the control of phage development during pseudolysogeny and in slowly growing host cells. Res Microbiol (2003) 1.06
Experimental evidence for the physiological role of bacterial luciferase in the protection of cells against oxidative stress. Curr Microbiol (2003) 1.05
ppGpp inhibits the activity of Escherichia coli DnaG primase. Plasmid (2009) 1.04
Growth-rate dependent RNA polyadenylation in Escherichia coli. EMBO Rep (2003) 1.03
Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases. J Appl Genet (2007) 0.98
Overexpression of the cgtA (yhbZ, obgE) gene, coding for an essential GTP-binding protein, impairs the regulation of chromosomal functions in Escherichia coli. Curr Microbiol (2002) 0.96
Stimulation of DNA repair as an evolutionary drive for bacterial luminescence. Luminescence (2003) 0.96
Impairment of glycosaminoglycan synthesis in mucopolysaccharidosis type IIIA cells by using siRNA: a potential therapeutic approach for Sanfilippo disease. Eur J Hum Genet (2009) 0.96
Transcription from bacteriophage lambda pR promoter is regulated independently and antagonistically by DksA and ppGpp. Nucleic Acids Res (2009) 0.95
Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different? Med Hypotheses (2010) 0.95
Expression of genes coding for GerA and GerK spore germination receptors is dependent on the protein phosphatase PrpE. J Bacteriol (2006) 0.95
Differential antibacterial activity of genistein arising from global inhibition of DNA, RNA and protein synthesis in some bacterial strains. Arch Microbiol (2005) 0.93
MDM2 gene amplification: a new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC). Lung Cancer (2004) 0.93
Effective inhibition of lytic development of bacteriophages lambda, P1 and T4 by starvation of their host, Escherichia coli. BMC Biotechnol (2007) 0.92
Correlation between severity of mucopolysaccharidoses and combination of the residual enzyme activity and efficiency of glycosaminoglycan synthesis. Acta Paediatr (2008) 0.92
Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses. Metab Brain Dis (2011) 0.92
Bacteriophage contamination: is there a simple method to reduce its deleterious effects in laboratory cultures and biotechnological factories? J Appl Genet (2004) 0.91
Two-year follow-up of Sanfilippo Disease patients treated with a genistein-rich isoflavone extract: assessment of effects on cognitive functions and general status of patients. Med Sci Monit (2011) 0.91
Genistein: a natural isoflavone with a potential for treatment of genetic diseases. Biochem Soc Trans (2010) 0.90
Plasmids derived from lambdoid bacteriophages as models for studying replication of mobile genetic elements responsible for the production of Shiga toxins by pathogenic Escherichia coli strains. J Mol Microbiol Biotechnol (2009) 0.89
RAPD typing of methicillin-resistant Staphylococcus aureus: a 7-year experience in a Polish hospital. Med Sci Monit (2007) 0.89
Genistein in Sanfilippo disease: a randomized controlled crossover trial. Ann Neurol (2012) 0.89
Drug-resistant epilepsia and fulminant valproate liver toxicity. Alpers-Huttenlocher syndrome in two children confirmed post mortem by identification of p.W748S mutation in POLG gene. Med Sci Monit (2011) 0.88
SeqA-mediated stimulation of a promoter activity by facilitating functions of a transcription activator. Mol Microbiol (2003) 0.88
Multiple mechanisms of transcription inhibition by ppGpp at the lambdap(R) promoter. J Biol Chem (2002) 0.88
Evaluation of biofilm production and prevalence of the icaD gene in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains isolated from patients with nosocomial infections and carriers. FEMS Immunol Med Microbiol (2007) 0.87
Improvement in the range of joint motion in seven patients with mucopolysaccharidosis type II during experimental gene expression-targeted isoflavone therapy (GET IT). Am J Med Genet A (2011) 0.87
ppGpp-dependent negative control of DNA replication of Shiga toxin-converting bacteriophages in Escherichia coli. J Bacteriol (2013) 0.86
DNA replication defect in the Escherichia coli cgtA(ts) mutant arising from reduced DnaA levels. Arch Microbiol (2006) 0.86
The cell surface protein Ag43 facilitates phage infection of Escherichia coli in the presence of bile salts and carbohydrates. Microbiology (2002) 0.86
Influence of the Escherichia coli oxyR gene function on lambda prophage maintenance. Arch Microbiol (2010) 0.86
The Obg subfamily of bacterial GTP-binding proteins: essential proteins of largely unknown functions that are evolutionarily conserved from bacteria to humans. Acta Biochim Pol (2005) 0.86
Ascaridoidea: a simple DNA assay for identification of 11 species infecting marine and freshwater fish, mammals, and fish-eating birds. Exp Parasitol (2002) 0.85
Direct stimulation of the lambdapaQ promoter by the transcription effector guanosine-3',5'-(bis)pyrophosphate in a defined in vitro system. J Biol Chem (2004) 0.85
A regulatory role for Staphylococcus aureus toxin-antitoxin system PemIKSa. Nat Commun (2013) 0.85
Abnormalities in the hair morphology of patients with some but not all types of mucopolysaccharidoses. Eur J Pediatr (2007) 0.85
Alleviation of mutagenic effects of polycyclic aromatic agents (quinacrine mustard, ICR-191 and ICR-170) by caffeine and pentoxifylline. Mutat Res (2003) 0.84
Localization of Escherichia coli poly(A) polymerase I in cellular membrane. Biochem Biophys Res Commun (2005) 0.84
Post mortem identification of deoxyguanosine kinase (DGUOK) gene mutations combined with impaired glucose homeostasis and iron overload features in four infants with severe progressive liver failure. J Appl Genet (2010) 0.84
The mechanism of regulation of bacteriophage lambda pR promoter activity by Escherichia coli DnaA protein. J Biol Chem (2003) 0.84
Impaired chromosome partitioning and synchronization of DNA replication initiation in an insertional mutant in the Vibrio harveyi cgtA gene coding for a common GTP-binding protein. Biochem J (2002) 0.84
Induction of light emission by luminescent bacteria treated with UV light and chemical mutagens. J Appl Genet (2002) 0.84
Coupling of transcription and replication machineries in λ DNA replication initiation: evidence for direct interaction of Escherichia coli RNA polymerase and the λO protein. Nucleic Acids Res (2010) 0.83
Sensitivity of dark mutants of various strains of luminescent bacteria to reactive oxygen species. Arch Microbiol (2005) 0.83
The C-terminal domain of the Escherichia coli RNA polymerase alpha subunit plays a role in the CI-dependent activation of the bacteriophage lambda pM promoter. Nucleic Acids Res (2007) 0.83
Molecular factors involved in the development of diabetic foot syndrome. Acta Biochim Pol (2012) 0.83
Comparison of the Ames test and a newly developed assay for detection of mutagenic pollution of marine environments. Mutat Res (2002) 0.82
Improved HPLC method for total plasma homocysteine detection and quantification. Acta Biochim Pol (2008) 0.82
A role for the common GTP-binding protein in coupling of chromosome replication to cell growth and cell division. Biochem Biophys Res Commun (2002) 0.82
Involvement of the cgtA gene function in stimulation of DNA repair in Escherichia coli and Vibrio harveyi. Microbiology (2003) 0.81
Optimisation of the microbiological mutagenicity assay based on genetically modified Vibrio harveyi strains. J Appl Genet (2005) 0.81
A model for regulation of ColE1-like plasmid replication by uncharged tRNAs in amino acid-starved Escherichia coli cells. Plasmid (2002) 0.81
Biodegradation of nodularin and effects of the toxin on bacterial isolates from the Gulf of Gdańsk. Water Res (2009) 0.81
Role of the RNA polymerase alpha subunits in CII-dependent activation of the bacteriophage lambda pE promoter: identification of important residues and positioning of the alpha C-terminal domains. Nucleic Acids Res (2004) 0.81
Bioluminescence-mediated stimulation of photoreactivation in bacteria. FEMS Microbiol Lett (2005) 0.81
Interplay between DnaA and SeqA proteins during regulation of bacteriophage lambda pR promoter activity. J Mol Biol (2003) 0.81
Detection of bacteriophage infection and prophage induction in bacterial cultures by means of electric DNA chips. Anal Biochem (2004) 0.81
Toxicity of the bacteriophage lambda cII gene product to Escherichia coli arises from inhibition of host cell DNA replication. Virology (2003) 0.81
Putative biological mechanisms of efficiency of substrate reduction therapies for mucopolysaccharidoses. Arch Immunol Ther Exp (Warsz) (2012) 0.81
tRNA-dependent cleavage of the ColE1 plasmid-encoded RNA I. Microbiology (2006) 0.81
Different amounts of isoflavones in various commercially available soy extracts in the light of gene expression-targeted isoflavone therapy. Phytother Res (2010) 0.80
Composition of the lambda plasmid heritable replication complex. Biochem J (2002) 0.80
Effects of hydrogen peroxide on light emission by various strains of marine luminescent bacteria. J Basic Microbiol (2004) 0.80
Changes in hair morphology of mucopolysaccharidosis I patients treated with recombinant human alpha-L-iduronidase (laronidase, Aldurazyme). Am J Med Genet A (2005) 0.80
Mechanisms of physiological regulation of RNA synthesis in bacteria: new discoveries breaking old schemes. J Appl Genet (2007) 0.80
Rapid deterioration of a patient with mucopolysaccharidosis type I during interruption of enzyme replacement therapy. Am J Med Genet A (2007) 0.80
Proteomic profiles and kinetics of development of bacteriophage T4 and its rI and rIII mutants in slowly growing Escherichia coli. J Gen Virol (2012) 0.80
Simultaneous siRNA-mediated silencing of pairs of genes coding for enzymes involved in glycosaminoglycan synthesis. Acta Biochim Pol (2012) 0.79
Clinical parameters of inflammatory bowel disease in children do not correlate with four common polymorphisms of the transforming growth factor β1 gene. Acta Biochim Pol (2011) 0.79
Sample processing for DNA chip array-based analysis of enterohemorrhagic Escherichia coli (EHEC). Microb Cell Fact (2008) 0.79
Transcription in the prpC-yloQ region in Bacillus subtilis. Arch Microbiol (2005) 0.79
Degradation of mutant initiator protein DnaA204 by proteases ClpP, ClpQ and Lon is prevented when DNA is SeqA-free. Biochem J (2003) 0.79
Homocysteine level and metabolism in ischemic stroke in the population of Northern Poland. Clin Biochem (2009) 0.79
Differential effects of Kid toxin on two modes of replication of lambdoid plasmids suggest that this toxin acts before, but not after, the assembly of the replication complex. Microbiology (2002) 0.79
Switch from theta to sigma replication of bacteriophage lambda DNA: factors involved in the process and a model for its regulation. Mol Genet Genomics (2007) 0.79
Methylxanthines (caffeine, pentoxifylline and theophylline) decrease the mutagenic effect of daunomycin, doxorubicin and mitoxantrone. Acta Biochim Pol (2005) 0.79
Modulation of lambda plasmid and phage DNA replication by Escherichia coli SeqA protein. Microbiology (2007) 0.79
Riboregulation of the bacterial actin-homolog MreB by DsrA small noncoding RNA. Integr Biol (Camb) (2015) 0.79
Metal and antibiotic resistance of bacteria isolated from the Baltic Sea. Int Microbiol (2012) 0.78
Synthetic genistein derivatives as modulators of glycosaminoglycan storage. J Transl Med (2012) 0.78
Genetic analysis of bacteriophage lambdaN-dependent antitermination suggests a possible role for the RNA polymerase alpha subunit in facilitating specific functions of NusA and NusE. Arch Microbiol (2003) 0.78